Partners

Gwo Xi’s GXNPC1® Receives TFDA Approval for Phase III Clinical Trial to Address Chronic Stroke-Related Disability

Gwo Xi Stem Cell Files Drug Master File (DMF) with FDA, Integrating into the Global Regenerative Medicine Industry Chain

Gwo Xi Stem Cell’s Diabetes Cell Therapy Product GXIPC1® Receives Phase I Trial Results Approval from Vietnam’s MOH